Drug Information

Drug General Information
Drug ID
D01NZS
Former ID
DNC012210
Drug Name
2-(6-Imidazol-1-yl-hexyl)-isoindole-1,3-dione
Drug Type
Small molecular drug
Indication Discovery agent Investigative [533459]
Structure
Download
2D MOL

3D MOL
Formula
C17H19N3O2
Canonical SMILES
C1=CC=C2C(=C1)C(=O)N(C2=O)CCCCCCN3C=CN=C3
InChI
1S/C17H19N3O2/c21-16-14-7-3-4-8-15(14)17(22)20(16)11-6-2-1-5-10-19-12-9-18-13-19/h3-4,7-9,12-13H,1-2,5-6,10-11H2
InChIKey
CGDDIOSGLRENCV-UHFFFAOYSA-N
PubChem Compound ID
13580026
Target and Pathway
Target(s) Thromboxane-A synthase Target Info Inhibitor [533459]
BioCyc Pathway C20 prostanoid biosynthesis
KEGG Pathway Arachidonic acid metabolism
Metabolic pathways
Platelet activation
PathWhiz Pathway Arachidonic Acid Metabolism
WikiPathways Prostaglandin Synthesis and Regulation
Arachidonic acid metabolism
Phase 1 - Functionalization of compounds
Eicosanoid Synthesis
References
Ref 533459J Med Chem. 1986 May;29(5):816-9.Thromboxane synthetase inhibitors and antihypertensive agents. 2. N-[(1H-imidazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones and N-[(1H-1,2,4-triazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones as unique antihypertensive agents.
Ref 533459J Med Chem. 1986 May;29(5):816-9.Thromboxane synthetase inhibitors and antihypertensive agents. 2. N-[(1H-imidazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones and N-[(1H-1,2,4-triazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones as unique antihypertensive agents.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.